Activation-state-selective targets
| id | gene_symbol | protein_name | activation_state_pdb_active | activation_state_pdb_inactive | opentargets_top_disease_name | evidence_priority |
|---|---|---|---|---|---|---|
| P08514 | ITGA2B | Integrin alpha-IIb | 8T2U | 8T2V | Glanzmann thrombasthenia 1 | 0.947 |
| P05106 | ITGB3 | Integrin beta-3 | 8T2U | 8T2V | Glanzmann thrombasthenia 1 | 0.946 |
| P01112 | HRAS | GTPase HRas | 5P21 | 4Q21 | Costello syndrome | 0.765 |
| P01116 | KRAS | GTPase KRas | 6GOD | 6MNX | Noonan syndrome 3 | 0.748 |
| P00519 | ABL1 | Tyrosine-protein kinase ABL1 | 2GQG | 1OPL | chronic myelogenous leukemia | 0.747 |
| P12931 | SRC | Proto-oncogene tyrosine-protein kinase Src | 1Y57 | 2SRC | cancer | 0.73 |
| P31749 | AKT1 | RAC-alpha serine/threonine-protein kinase | 4EJN | 3O96 | Proteus syndrome | 0.728 |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | 2W96 | 3G33 | melanoma, cutaneous malignant, susceptibility to, 3 | 0.714 |
| O14965 | AURKA | Aurora kinase A | 1OL5 | 1MUO | neurodegenerative disease | 0.656 |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | 1QMZ | 1HCK | neurodegenerative disease | 0.652 |
| P06756 | ITGAV | Integrin alpha-V | 1L5G | 1JV2 | neurodegenerative disease | 0.581 |